Condividi contenuti The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Aggiornato: 32 min 46 sec fa

Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM(TM) S-ICD System

Mar, 03/17/2015 - 21:03
Innovative device offers first-line treatment for patients at risk of sudden cardiac arrest MARLBOROUGH, Mass., March 17, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) has received FDA and CE Mark approval of the...
Devices, Cardiology, Regulatory
Boston Scientific, EMBLEM S-ICD, Subcutaneous Implantable Defibrillator

CVRx(R) Barostim Therapy(TM) for Heart Failure Clinical Trial Results Presented in a Featured Clinical Research Session of the American College of Cardiology Annual Conference

Mar, 03/17/2015 - 13:44
MINNEAPOLIS, March 17, 2015 -- (Healthcare Sales & Marketing Network) -- CVRx, Inc., a private medical device company, announced that positive results from the Barostim Therapy for Heart Failure randomized, controlled clinical trial were presented at Amer...
Devices, Cardiology
CVRx, Barostim Therapy, Barostim neo, heart failure, hypertension

Sirtex Reports Preliminary SIRFLOX Study Results

Mar, 03/17/2015 - 13:36
In the first-line treatment of non-resectable metastatic colorectal cancer: SIRFLOX study does not show a statistically significant improvement in overall Progression-Free Survival. SIRFLOX study does show a statistically significant improvement in ...
Devices, Drug Delivery, Oncology
Sirtex Medical, SIRFLOX study, SIR-Spheres, mCRC

Elekta Expands in Poland Through Acquisition

Mar, 03/17/2015 - 13:28
STOCKHOLM, Sweden--(Healthcare Sales & Marketing Network)--Elekta (STO:EKTAB) has today completed its acquisition of Polish distributor, RTA, as announced August 25, 2014. This deal will allow Elekta to leverage RTA’s existing relationships in order to str...
Devices, Distribution, Oncology, Acquisitions
Elekta, RTA, radiotherapy, radiosurgery

Jakavi(R) (ruxolitinib) Receives European Commission Approval as First Targeted Therapy for Patients with Polycythemia Vera

Mar, 03/17/2015 - 13:21
WILMINGTON, Del.--(Healthcare Sales & Marketing Network)--Incyte Corporation (Nasdaq: INCY) announced today that Novartis received approval from the European Commission for Jakavi® (ruxolitinib) for the treatment of adult patients with polycythemia ver...
Biopharmaceuticals, Oncology, Regulatory
Incyte, Jakavi, Jakafi, ruxolitinib, polycythemia vera

Vascular Solutions Launches PolarCath(TM) Peripheral Dilatation System

Lun, 03/16/2015 - 21:31
MINNEAPOLIS, March 16, 2015 -- (Healthcare Sales & Marketing Network) -- Vascular Solutions, Inc. (VASC) today announced that it has commenced sales of the PolarCath peripheral dilatation system in the United States in collaboration with NuCryo Vascular LL...
Devices, Interventional, Product Launch
Vascular Solutions, NuCryo Vascular, PolarCath, peripheral dilatation

Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer

Lun, 03/16/2015 - 13:35
CAMBRIDGE, Mass., March 16, 2015 -- (Healthcare Sales & Marketing Network) -- Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™ across a range of therapeutic applications, announced today that Tal Zaks, M.D., Ph.D., ...
Biopharmaceuticals, Oncology, Personnel
Moderna Therapeutics

Chiasma Announces Mark Leuchtenberger as Chief Executive Officer

Lun, 03/16/2015 - 13:28
Proven Business Leader to Oversee Commercialization of Octreotide Capsules NEWTON, Mass. and JERUSALEM, March 16, 2015 -- (Healthcare Sales & Marketing Network) -- Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, i...
Biopharmaceuticals, Personnel
Chiasma, octreotide

Astute Medical, Inc. Previews International Intensive Care Meeting

Lun, 03/16/2015 - 13:21
SAN DIEGO, March 16, 2015 -- (Healthcare Sales & Marketing Network) -- Astute Medical, Inc., developer of the NEPHROCHECK® Test, today previewed abstracts to be presented next week at the International Symposium on Intensive Care and Emergency Medicin...
Astute Medical, NEPHROCHECK, acute kidney injury

Boston Scientific Receives FDA Approval for WATCHMAN(TM) Left Atrial Appendage Closure Device

Ven, 03/13/2015 - 14:25
First-Of-Its-Kind Alternative to Long-Term Warfarin Therapy for Stroke Risk Reduction in Patients with Non-Valvular Atrial Fibrillation MARLBOROUGH, Mass., March 13, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE:...
Devices, Cardiology, FDA
Boston Scientific, WATCHMAN Device, Left Atrial Appendage Closure Device

Minerva Neurosciences Announces $31 Million Financing

Ven, 03/13/2015 - 14:05
WALTHAM, Mass., March 13, 2015 -- (Healthcare Sales & Marketing Network) -- Minerva Neurosciences, Inc. (NERV) today announced that it will raise approximately $31 million of gross proceeds in a private placement offering to several institutional investors...
Biopharmaceuticals, Neurology, Venture Capital
Minerva Neurosciences, schizophrenia

Actavis Receives FDA Approval of SAPHRIS(R) for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder

Ven, 03/13/2015 - 13:58
First atypical antipsychotic to be approved for pediatric patients with bipolar I disorder in the last five years Important additional treatment option for children and teens DUBLIN, March 13, 2015 -- (Healthcare Sales & Marketing Network) -- Actavi...
Biopharmaceuticals, FDA
Actavis , antipsychotic, SAPHRIS, asenapine, bipolar

Toshiba’s Aplio Platinum Series CV Helps Provide More Confident Cardiac Diagnoses

Ven, 03/13/2015 - 13:45
Dedicated Cardiac System for All 2D Imaging Needs TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--ACC Booth #1916 – Physicians can deliver superior cardiac diagnoses at the patient’s side with the new Aplio™ Platinum Series CV ultrasound system...
Devices, Cardiology, Product Launch
Toshiba America Medical Systems, Aplio , ultrasound, Aplio 500 Platinum CV

Toshiba’s Infinix 4DCT Receives FDA Clearance with Aquilion PRIME CT Configuration

Ven, 03/13/2015 - 13:38
First Interventional Lab and CT Solution Puts Customers First with Safer, Faster and Accurate Interventions TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--ACC Booth #1916 – Expanding the industry’s first seamless integration between interventio...
Devices, Interventional, Radiology, FDA
Toshiba America Medical Systems, Infinix 4DCT, Aquilion PRIME CT

Endologix Announces Chief Financial Officer Transition

Gio, 03/12/2015 - 16:04
IRVINE, Calif., March 12, 2015 -- (Healthcare Sales & Marketing Network) -- Endologix, Inc. (ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief Financial Officer, has decided to resign fr...
Devices, Interventional, Personnel
Endologix, endovascular stent graft, abdominal aortic aneurysm

CryoLife Provides Update on PerClot Litigation

Gio, 03/12/2015 - 16:01
ATLANTA, March 12, 2015 -- (Healthcare Sales & Marketing Network) -- CryoLife, Inc. (CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, today provided an update on its ongoing litigation with C.R. Bard, I...
Devices, Surgery, Litigation
CryoLife, C.R. Bard, PerClot, hemostat

JACC Reports on First-In-Human Transcatheter Tricuspid Repair

Gio, 03/12/2015 - 15:55
Mitralign Transcatheter Annuloplasty System could present a non-surgical option for both mitral and tricuspid valve regurgitation TEWKSBURY, Mass.--(Healthcare Sales & Marketing Network)--A detailed reporting of the first successful case of a direct tra...
Devices, Interventional Cardiology
Mitralign, Transcatheter Annuloplasty, mitral regurgitation, tricuspid

Volcano receives CE mark for iFR Scout Pullback software to help diagnose serial lesions and diffuse coronary disease

Gio, 03/12/2015 - 15:52
AMSTERDAM and SAN DIEGO , March 12, 2015 (Healthcare Sales & Marketing Network) -- Royal Philips (NYSE: PHG; AEX: PHIA), today announced that Volcano, a Philips business, has received CE Mark for the iFR Scout pullback software, a functional extension of ...
Devices, Interventional Cardiology, Regulatory
Royal Philips, Volcano, iFR Scout, Fractional Flow Reserve

Varian Medical Systems Selected to Equip Two National Proton Therapy Centers in England

Mer, 03/11/2015 - 22:18
CRAWLEY, England, March 11, 2015 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) today announced that it has been selected to equip and service two new national proton therapy centers in England with the Varian ProBeam® proto...
Devices, Oncology
Varian Medical Systems, proton therapy, ProBeam, radiotherapy

Cardiac Dimensions(R) Completes $43M Equity Financing

Mer, 03/11/2015 - 22:10
$15.2 Million Infusion from International Investors Rounds Out Financing; Funds Will Support Landmark Trial, Expand Commercial Operations KIRKLAND, Wash., March 11, 2015 -- (Healthcare Sales & Marketing Network) -- Cardiac Dimensions® today announc...
Devices, Cardiology, Venture Capital
Cardiac Dimensions, percutaneous mitral repair, CARILLON, mitral regurgitation

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong